Van Hulzen Asset Management, LLC Seagen Inc. Transaction History

Van Hulzen Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$108.81 - $179.33 $232,309 - $382,869	-2,135 Closed	0 $0
Q1 2022 May 20, 2022	SELL	$119.61 - $157.85 $28,706 - $37,884	-240 Reduced 10.11%	2,135 $308,000
Q4 2021 Feb 04, 2022	BUY	$142.57 - $190.86 $7,128 - $9,543	50 Added 2.15%	2,375 $367,000
Q3 2021 Nov 12, 2021	BUY	$142.45 - $169.82 $331,196 - $394,831	2,325 New	2,325 $395,000
Q1 2021 May 12, 2021	SELL	$137.51 - $190.8 $234,454 - $325,314	-1,705 Closed	0 $0

Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $280,694 - $361,340	1,705 New	1,705 $299,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Van Hulzen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Van Hulzen Asset Management, LLC with notifications on news.